EVAR with No Complications in Octogenarians: Survival Rate Identical to that of Healthy Octogenarians

This analysis reports (for the first time in the literature) that after the endovascular aortic aneurysm repair (EVAR) in octogenarians, survival rate is the same as that of their healthy counterparts.  

Pacientes que no siguen nuestro consejo y sorpresivamente tienen menos eventos

This is true provided the procedure does not present complications. If any, mortality results twice as high in this group. 

Using propensity score, researchers compared octogenarians with identical comorbidities undergoing EVAR vs. others with no aortic aneurysm from the Rotterdam study.

Complications rate for this procedure resulted 27% (mainly cardiac, pulmonary and access complications). This represents twice as many complications than in younger patients, which emphasizes the importance of correct patient selection.


Read also: Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?


After uncomplicated EVAR, mortality results similar vs the control group in the Rotterdam trial (HR 1.09, CI 95% 0.68 to 1.77). However, should there be any complications, these figures would see a dramatic change (HR 1.93, CI 95% 1.06 to 3.54).

Conclusion

After uncomplicated EVAR in 80+ patients, survival rate is the same as their healthy contemporaries. 

Patient selection and perioperatory care should be carried out thoroughly. 

Original Title: Survival After Uncomplicated EVAR in Octogenarians is Similar to the General Population of Octogenarians Without an Abdominal Aortic Aneurysm.

Reference: Oscar L. Rueda-Ochoa et al. Eur J Vasc Endovasc Surg, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...